Print Icon

Your Micro-Dose of Cannabis Information

Deconstructed: Investing In NY Cannabis

New York is the 15th state to legalize cannabis sales to all adults, expected to create over 60,000 jobs and to generate over $350 million in tax revenue. Business Insider views this market as having $7 billion in sales potential, and we view it as an important inflection point to the East Coast domino effect. Once Connecticut and Pennsylvania follow suit, the Northeast will rival California’s position as the leading cannabis market – providing incredible opportunities for aspiring investors. 

                           Progress Beats Perfection Every Time

We are pleased to see the Marijuana Regulation and Taxation Act (MRTA) setting a goal to award 50% of licenses to social equity applicants.  These are defined as "those from communities disproportionately impacted by the drug war, minorities, women, small or distressed farmers, and service-disabled veterans." We hold out hope that this is implemented with fairness and without the corruption rampant in its IL counterpart.

The NY market will operate in two tiers. With the exception of incumbents, operators can act as cultivators or retailers. This provides a significant advantage for existing medical retailers and bars new entrants from forming vertically integrated businesses. Expect to see increased M&A activity as deals with current medical operators provide vertical leverage to new operators.

Those Who Don’t Want To Change. Let Them Sleep.

What MAZAKALI Can Do For You 


MAZAKALI is a Registered Investment Adviser and provides access to direct investment opportunities as well as managed investments such as SPVS (Special Purpose Vehicles), SMAs (Separately Managed Accounts) and third-party funds. 



MAZAKALI is actively seeking to facilitate $20,000,000 of investment into cannabis related businesses with check sizes ranging from $100,000 up to $5,000,000.



Investing in private placement securities entails a high degree of risk, including illiquidity of the investment and loss of principal. Please read the offering document before investing. Please refer to the Company’s subscription agreement for a discussion of risk factors.

Securities offered through Growth Capital Services, Inc. (“GCS”), a licensed broker-dealer and member of FINRA/SIPC, office of supervisory jurisdiction located at 582 Market Street, Suite 300, San Francisco, CA 94104.

Not interested? Unsubscribe | Update profile
MAZAKALI | San Francisco, CA